Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Pneumococcal disease
English (EN)
NITAG documentation
2021
2002
Clear all
Type of publications
NITAG documentation
(114)
SAGE documentation
(6)
Topics
Agenda & Minutes
(1)
Background paper
(27)
Recommendation
(86)
Available to download in languages
English (EN)
(114)
French (FR)
(37)
Spanish (ES)
(12)
German (DE)
(7)
Swedish (SV)
(1)
Regions
Africa
(13)
Americas
(52)
Europe
(36)
South-East Asia
(2)
Western Pacific
(11)
Countries
Diseases
COVID-19
(112)
Pneumococcal disease
(2)
Diphtheria
(1)
Ebola
(1)
Herpes zoster
(1)
Influenza
(3)
Poliomyelitis
(1)
Rotavirus
(2)
Varicella
(1)
Yellow fever
(2)
Vaccine topics
Target population
Adults
(2)
Children
(2)
Older adults
(1)
Pregnant women
(3)
Risk group
(1)
Publication date
2021
(112)
2002
(2)
2024
(4)
2023
(22)
2022
(55)
2020
(65)
2019
(5)
2018
(6)
2017
(2)
2016
(2)
2015
(3)
2014
(3)
2013
(3)
2012
(2)
2011
(1)
2010
(4)
2008
(1)
2005
(1)
2004
(2)
2003
(3)
1997
(1)
114 results found
2021
∙
JCVI
Use of the AstraZeneca COVID-19 (AZD1222) vaccine: updated JCVI statement, 7 May 2021
2021
∙
Conseil Supérieur de la Santé (CSS)
Vaccination against COVID-19 in pregnant and breastfeeding women
2002
∙
ACIP
Pneumococcal Vaccination for Cochlear Implant Recipients
2002
∙
ACIP
Pneumococcal Vaccination for Cochlear Implant Recipients
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register